tiprankstipranks
KalVista Pharmaceuticals (KALV)
NASDAQ:KALV
KALV
KalVista Pharmaceuticals
RESEARCH TOOLSreports
Want to see KALV full AI Analyst Report?

KalVista Pharmaceuticals (KALV) Revenue

618 Followers
StatisticsMarket CapRevenue

KalVista Pharmaceuticals Revenue

KalVista Pharmaceuticals had a revenue of 59.92M in the quarter ending Oct 31, 2025, with 337.66%. This bring the company's revenue in the last twelve months to 75.04M, Decreased 396.38%. In the fiscal year ending Dec 31, 2025, KalVista Pharmaceuticals had annual revenue of 73.62M with Infinity% growth.
Revenue (ttm)
75.04M
Revenue Growth
―
P/S Ratio
18.54
Revenue/Employee
$490,780
Employees
150
Market Cap
$1.37B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
73.62M―+∞%
Apr 30, 2025
―――
Apr 30, 2024
―――
Apr 30, 2023
―――
Apr 30, 2022
―――
Apr 30, 2021
―-12.69M-100.00%
Apr 30, 2020
12.69M-3.44M-21.31%
Apr 30, 2019
16.13M7.73M+92.13%
Jul 31, 2018
8.39M6.89M+458.11%
Apr 30, 2017
1.50M――